Moe SM - Search Results

1

Baseline characteristics of subjects enrolled in the Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) trial.

Chertow GM, Correa-Rotter R, Block GA, Drueke TB, Floege J, Goodman WG, Herzog CA, Kubo Y, London GM, Mahaffey KW, Mix TC, Moe SM, Wheeler DC, Parfrey PS. Chertow GM, et al. Among authors: moe sm. Nephrol Dial Transplant. 2012 Jul;27(7):2872-9. doi: 10.1093/ndt/gfr777. Epub 2012 Apr 23. Nephrol Dial Transplant. 2012. PMID: 22529163 Clinical Trial.

2

The calcimimetic AMG 073 reduces parathyroid hormone and calcium x phosphorus in secondary hyperparathyroidism.

Lindberg JS, Moe SM, Goodman WG, Coburn JW, Sprague SM, Liu W, Blaisdell PW, Brenner RM, Turner SA, Martin KJ. Lindberg JS, et al. Among authors: moe sm. Kidney Int. 2003 Jan;63(1):248-54. doi: 10.1046/j.1523-1755.2003.00720.x. Kidney Int. 2003. PMID: 12472790 Free article. Clinical Trial.

3

Assessment of vascular calcification in ESRD patients using spiral CT.

Moe SM, O'Neill KD, Fineberg N, Persohn S, Ahmed S, Garrett P, Meyer CA. Moe SM, et al. Nephrol Dial Transplant. 2003 Jun;18(6):1152-8. doi: 10.1093/ndt/gfg093. Nephrol Dial Transplant. 2003. PMID: 12748349

4

Management of secondary hyperparathyroidism: the importance and the challenge of controlling parathyroid hormone levels without elevating calcium, phosphorus, and calcium-phosphorus product.

Moe SM, Drüeke TB. Moe SM, et al. Am J Nephrol. 2003 Nov-Dec;23(6):369-79. doi: 10.1159/000073945. Epub 2003 Oct 9. Am J Nephrol. 2003. PMID: 14551461 Review.

5

Disturbances of bone and mineral metabolism in chronic kidney disease: an international initiative to improve diagnosis and treatment.

Drüeke TB, Moe SM. Drüeke TB, et al. Among authors: moe sm. Nephrol Dial Transplant. 2004 Mar;19(3):534-6. doi: 10.1093/ndt/gfh034. Nephrol Dial Transplant. 2004. PMID: 14767004 Review. No abstract available.

6

A bridge to improving healthcare outcomes and quality of life.

Moe SM, Drüeke TB. Moe SM, et al. Am J Kidney Dis. 2004 Mar;43(3):552-7. doi: 10.1053/j.ajkd.2003.12.002. Am J Kidney Dis. 2004. PMID: 14981614 No abstract available.

7

Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis.

Block GA, Martin KJ, de Francisco AL, Turner SA, Avram MM, Suranyi MG, Hercz G, Cunningham J, Abu-Alfa AK, Messa P, Coyne DW, Locatelli F, Cohen RM, Evenepoel P, Moe SM, Fournier A, Braun J, McCary LC, Zani VJ, Olson KA, Drüeke TB, Goodman WG. Block GA, et al. Among authors: moe sm. N Engl J Med. 2004 Apr 8;350(15):1516-25. doi: 10.1056/NEJMoa031633. N Engl J Med. 2004. PMID: 15071126 Free article. Clinical Trial.

8

Natural history of vascular calcification in dialysis and transplant patients.

Moe SM, O'Neill KD, Reslerova M, Fineberg N, Persohn S, Meyer CA. Moe SM, et al. Nephrol Dial Transplant. 2004 Sep;19(9):2387-93. doi: 10.1093/ndt/gfh303. Epub 2004 Jul 13. Nephrol Dial Transplant. 2004. PMID: 15252163

9

Calcification or classification?

Chertow GM, Moe SM. Chertow GM, et al. Among authors: moe sm. J Am Soc Nephrol. 2005 Feb;16(2):293-5. doi: 10.1681/ASN.2004121115. Epub 2005 Jan 12. J Am Soc Nephrol. 2005. PMID: 15647332 No abstract available.

10

Achieving NKF-K/DOQI bone metabolism and disease treatment goals with cinacalcet HCl.

Moe SM, Chertow GM, Coburn JW, Quarles LD, Goodman WG, Block GA, Drüeke TB, Cunningham J, Sherrard DJ, McCary LC, Olson KA, Turner SA, Martin KJ. Moe SM, et al. Kidney Int. 2005 Feb;67(2):760-71. doi: 10.1111/j.1523-1755.2005.67139.x. Kidney Int. 2005. PMID: 15673327 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

289 results

Search Page

Filters